Characterization of the serotonin transporter knockout rat: A selective change in the functioning of the serotonergic system (original) (raw)

Abstract

Here, we describe the functional characterization of the serotonin transporter (SERT) knockout rat model, that is generated by N-ethyl-N-nitrosurea (ENU)-driven target-selected mutagenesis. Biochemical characterization revealed that SERT mRNA and functional protein are completely absent in homozygous knockout (SERT ؊/؊ ) rats, and that there is a gene dose-dependent reduction in the expression and function of the SERT in heterozygous knockout rats. As a result, 5-HT homeostasis was found to be severely affected in SERT ؊/؊ rats: 5-HT tissue levels and depolarization-induced 5-HT release were significantly reduced, and basal extracellular 5-HT levels in the hippocampus were ninefold increased. Interestingly, we found no compensatory changes in in vitro activity of tryptophan hydroxylase and monoamine oxidase, the primary enzymes involved in 5-HT synthesis and degradation, respectively. Similarly, no major adaptations in nonserotonergic systems were found, as determined by dopamine and noradrenaline transporter binding, monoamine tissue levels, and depolarization-induced release of dopamine, noradrenaline, glutamate and GABA. In conclusion, neurochemical changes in the SERT knockout rat are primarily limited to the serotonergic system, making this novel rat model potentially very useful for studying the behavioral and neurobiological consequences of disturbed 5-HT homeostasis. transporter; SERT Ϫ/Ϫ , homozygous serotonin transporter knockout rat; SERT ϩ/Ϫ , heterozygous serotonin transporter knockout rat; SERT ϩ/ϩ , wildtype littermate of heterozygous serotonin transporter knockout and homozygous serotonin transporter knockout rats; SSRI, selective serotonin reuptake inhibitor; TPH, tryptophan hydroxylase; 5-HIAA, 5-hydroxyindoleacetic acid; 5-HTP, 5-hydroxytryptophan.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (50)

  1. Adamec R, Burton P, Blundell J, Murphy DL, Holmes A (2006) Vul- nerability to mild predator stress in serotonin transporter knockout mice. Behav Brain Res 170:126 -140.
  2. Baker KE, Parker R (2004) Nonsense-mediated mRNA decay: terminating erroneous gene expression. Curr Opin Cell Biol 16: 293-299.
  3. Bengel D, Greenberg BD, Cora-Locatelli G, Altemus M, Heils A, Li Q, Murphy DL (1999) Association of the serotonin transporter pro- moter regulatory region polymorphism and obsessive-compulsive disorder. Mol Psychiatry 4:463-466.
  4. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mössner R, Westphal H, Lesch K-P (1998) Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymeth- amphetamine ('ecstasy') in serotonin transporter-deficient mice. Mol Pharmacol 53:649-655.
  5. Benmansour S, Cecchi M, Morilak DA, Gerhardt GA, Javors MA, Gould GG, Frazer A (1999) Effects of chronic antidepressant treat- ments on serotonin transporter function, density and mRNA level. J Neurosci 19:10494 -10501.
  6. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003) Influ- ence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386 -389.
  7. Cremers TI, Giorgetti M, Bosker FJ, Hogg S, Arnt J, Mork A, Honig G, Bogeso KP, Westerink BH, den Boer H, Wilkstrom HV, Tecott LH (2004) Inactivation of 5-HT(2C) receptors potentiates conse- quences of serotonin reuptake blockade. Neuropsychopharmacol- ogy 10:1782-1789.
  8. Daws LC, Toney GM, Gerhardt GA, Frazer A (1998) In vivo chrono- amperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: contribution of serotonin and norepinephrine transporters. J Pharmacol Exp Ther 286:967-976.
  9. Fabre V, Beaufour C, Evrard A, Rioux A, Hanoun N, Lesch K-P, Murphy DL, Lanfumey L, Hamon M, Martres MP (2000) Altered expression and functions of serotonin 5-HT1A and 5-HT1B recep- tors in knock-out mice lacking the 5-HT transporter. Eur J Neurosci 12:2299 -2310.
  10. Gainetdinov RR, Jones SR, Fumagalli F, Wightman RM, Caron MG (1998) Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis. Brain Res Brain Res Rev 26:148 -153.
  11. Gerra G, Garofano L, Santoro G, Bosari S, Pellegrino C, Zaimovic A, Moi G, Bussandri M, Moi A, Brambilla F, Donnini C (2004) Asso- ciation between low-activity serotonin transporter genotype and heroin dependence: behavioral and personality correlates. Am J Med Genet B Neuropsychiatr Genet 126:37-42.
  12. Gobbi G, Murphy DL, Lesch K-P, Blier P (2001) Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. J Pharmacol Exp Ther 296: 987-995.
  13. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL (1999) Genetic variation in the serotonin transporter promotor re- gion affects serotonin uptake in human blood platelets. Am J Med Genet 88:83-87.
  14. Hamon M, El Mestikawy S, Lanfumey L, Adrien J, Fattaccini CM, Gozlan H (1991) Somato-dendritic 5-HT1A autoreceptors in the dorsal raphe nucleus: pharmacological and functional properties. In: Presynaptic receptors and neuronal transporters. Advances in the biosciences, Vol. 82 (Galzin SZ, Costenin AM, eds), pp 71-74. Oxford: Pergamon Press.
  15. Hariri AR, Mattay VS, Tessitore A, Kolachana, Fera F, Goldman D, Egan MF, Weinberger DR (2002) Serotonin transporter genetic variation and the response of the human amygdala. Science 297:400 -403.
  16. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch K-P (1996) Allelic variation of human serotonin transporter gene ex- pression. J Neurochem 66:2621-2624.
  17. Holmes A, Li Q, Murphy DL, Gold E, Crawley JN (2003) Abnormal anxiety-related behaviour in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav 2:365-380.
  18. Holmes A, Murphy DL, Crawley JN (2002a) Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology 161: 160 -167.
  19. Holmes A, Yang JL, Murphy DL, Crawley JN (2002b) Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology 27:914 -923.
  20. Jaber M, Dumartin B, Sagne C, Haycock JW, Roubert C, Giros B, Bloch B, Caron MG (1999) Differential regulation of tyrosine hy- droxylase in the basal ganglia of mice lacking the dopamine trans- porter. Eur J Neurosci 11:3499 -3511.
  21. Kim DK, Tolliver TJ, Huang SJ, Martin BJ, Andrews AM, Wichems C, Holmes A, Lesch K-P, Murphy DL (2005) Altered serotonin syn- thesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology 49: 798 -810.
  22. Lauder JM (1990) Ontogeny of the serotonin system in the rat: sero- tonin as a developmental signal. Ann N Y Acad Sci 600:297-313.
  23. Lesch K-P, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996) Association of anxiety-related traits with a polymorphism in the serotonin trans- porter gene regulatory region. Science 274:1527-1531.
  24. Li Q, Wichems C, Heils A, Lesch K-P, Murphy DL (2000) Reduction in the density and expression, but not G-protein coupling, of seroto- nin receptors (5-HT 1A ) in 5-HT transporter knock-out mice: gender and brain region differences. J Neurosci 20:7888 -7895.
  25. Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, Francis JH, Bradley-Moore M, Lira J, Underwood MD, Arango V, Kung HF, Hofer MA, Hen R, Gingrich JA (2003) Altered depression-related behaviours and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol Psychiatry 54:960 -971.
  26. Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR, DellProposto ZS, Hill E, Cassin BJ, Watson SJ, Cook EH (1998) Cocaine, ethanol and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 155:207-213.
  27. Mathews TA, Fedele DE, Coppelli FM, Avila AM, Murphy DL, Andrews AM (2004) Gene dose-dependent alterations in extraneuronal se- rotonin but not dopamine in mice with reduced serotonin trans- porter expression. J Neurosci Methods 140:169 -181.
  28. Montañez S, Owens WA, Gould GG, Murphy DL, Daws LC (2003) Exaggerated effect of fluvoxamine in heterozygote serotonin trans- porter knockout mice. J Neurochem 86:210 -219.
  29. Moret C, Briley M (1999) Serotonin autoreceptor subsensitivity and antidepressant activity. Eur J Pharmacol 180:351-356.
  30. Moron JA, Brockington A, Wise RA, Rocha BA, Hope BT (2002) Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mice lines. J Neurosci 22:389 -395.
  31. Murphy DL, Andrews AM, Wichems CH, Li Q, Tohda M, Greenberg B (1998) Brain serotonin neurotransmission: an overview and update with an emphasis on serotonin subsystem heterogeneity, multiple receptors, interactions with other neurotransmitter systems, and consequent implications for understanding the action of serotoner- gic drugs. J Clin Psychiatry 59 (Suppl 15):4 -12.
  32. Murphy DL, Lerner A, Rudnick G, Lesch K-P (2004) Serotonin transporter: Gene, genetic disorders and pharmacogenetics. Mol Interv 4:109 -123.
  33. Nickerson DA, Tobe VO, Taylor SL (1997) PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 25: 2745-2751.
  34. Pan Y, Gembom E, Peng W, Lesch KP, Mossner R, Simantov R (2001) Plasticity in serotonin uptake in primary neuronal cultures of serotonin transporter knockout mice. Brain Res Dev Brain Res 126:125-129.
  35. Patel PD, Pontrello C, Burke S (2004) Robust and tissue-specific expression of TPH2 versus TPH1 in rat raphe and pineal gland. Biol Psychiatry 55:428 -433.
  36. Ritz MC, Cone EJ, Kuhar MJ (1990) Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci 46:635-645.
  37. Ritz MC, Kuhar MJ (1989) Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine. J Pharmacol Exp Ther 248:1010 -1017.
  38. Rocha BA, Fumagalli F, Gainetdinov RR, Jones SR, Ator R, Giros B, Miller GW, Caron MG (1998) Cocaine self-administration in do- pamine-transporter knockout mice. Nat Neurosci 1:132-137.
  39. Schmitt A, Mössner R, Gossmann A, Fischer IG, Gorboulev V, Murphy DL, Koepsell H, Lesch K-P (2003) Organic cation transporter ca- pable of transporting serotonin is upregulated in serotonin transporter-deficient mice. J Neurosci Res 71:701-709.
  40. Schoffelmeer ANM, Rice KC, Jacobson AE, Van Gelderen JG, Ho- genboom F, Mulder AH (1988) Mu,-delta-and kappa-opioid re- ceptor-mediated inhibition of neurotransmitter release and adenyl- ate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate. Eur J Pharmacol 154:169 -178.
  41. Shen HW, Hagino Y, Kobayashi H, Shinohara-Tanaka K, Ikeda K, Yamamoto H, Yamamoto T, Lesch K-P, Murphy DL, Hall FS, Uhl GR, Sora I (2004) Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacol- ogy 29:1790 -1799.
  42. Shih JC, Chen K, Ridd MJ (1999) Role of MAO A and B in neurotrans- mitter metabolism and behaviour. Pol J Pharmacol 121:941-946.
  43. Smits BMG, Mudde J, Plasterk RHA, Cuppen E (2004) Target-se- lected mutagenesis of the rat. Genomics 83:332-334.
  44. Smits BM, Mudde JB, van de Belt J, Verheul M, Olivier J, Homberg J, Guryev V, Cools AR, Ellenbroek BA, Plasterk RH, Cuppen E (2006) Generation of gene knockouts and mutant models in the laboratory rat by ENU-driven target-selected mutagenesis. Phar- macogenet Genomics 16:159 -169.
  45. Sora I, Wichems C, Takahashi N, Li XF, Zeng Z, Revay R, Lesch K-P, Murphy DL, Uhl GR (1998) Cocaine reward models: conditioned place preference can be established in dopamine-and in serotonin- transporter knockout mice. Proc Natl Acad Sci U S A 13:7699 - 7704.
  46. Vizi ES, Zsilla G, Caron MG, Kiss JP (2004) Uptake and release of norepinephrine by serotonergic terminals in norepinephrine trans- porter knockout-mice: implications for the action of selective sero- tonin reuptake inhibitors. J Neurosci 24:7888 -7894.
  47. Vrana SL, Dworkin SI, Vrana KE (1993) Radioenzymatic assay for tryptophan hydroxylase: [ 3 H]H 2 O release assessed by charcoal adsorption. J Neurosci Methods 48:123-129.
  48. Xu F, Gainetdinov PR, Wetsel WC, Jones SR, Bohn LM, Miller GW, Wang Y-M, Caron MG (2000) Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat Neurosci 5:465-471.
  49. Zan Y, Haag JD, Chen KS, Shepel LA, Wigington D, Wang YR, Hu R, Lopez-Guajardo CC, Brose HL, Porter KI, Leonard RA, Hitt AA, Schommer SL, Elegbede AF, Gould MN (2003) Production of knockout rats using ENU mutagenesis and a yeast-based screen- ing assay. Nat Biotech 21:645-651.
  50. Zhou FC, Lesch K-P, Murphy DL (2002) Serotonin uptake into dopa- mine neurons via dopamine transporters: a compensatory alterna- tive. Brain Res 942:109 -119.